Clinical trial
HArnessing Near-infrared Spectroscopy Intravascular Ultrasound Imaging for Yielding Advanced Guidance - PCSK9i for Improving Cardiovascular Outcome in High-Risk Patients
NCT07084259 is registered in ClinicalTrials.gov with Hanyang University Seoul Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HArnessing Near-infrared Spectroscopy Intravascular Ultrasound Imaging for Yielding Advanced Guidance - PCSK9i for Improving Cardiovascular Outcome in High-Risk Patients
- Lead sponsor
- Hanyang University Seoul Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- July 31, 2025
- Completion date
- July 31, 2030
- Enrollment
- 352 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.